Pseudorabies Virus UL41 Hijacks IFN Response via JAK/STAT Pathway While Cellular TRIM21 Blocks it Through K48 Ubiquitination

伪狂犬病毒UL41通过JAK/STAT通路劫持IFN反应,而细胞TRIM21则通过K48泛素化阻断该反应。

阅读:2

Abstract

Pseudorabies virus (PRV), a significant pathogen that infects various animals, including pigs, encodes multiple proteins that participate in host-pathogen interactions. This study investigates the mechanisms by which PRV evades host immune responses, with a particular focus on the role of the UL41 protein and its interactions with host factors. We found that PRV infection modulates the interferon (IFN) signaling pathway, suppressing the expression of IFN-β and downstream antiviral factors while upregulating IFN-α. However, the direct role of UL41 in IFN-α upregulation remains to be elucidated. The PRV UL41 protein was shown to directly target the JAK/STAT pathway, binding to specific motifs, such as the conserved sequences KUUUCY and CSDGGA, in the untranslated region (UTR) of key mRNAs and degrading them, thereby inhibiting IFN-I signal transduction. Simultaneously, the UL41 can interact with host proteins, such as poly(A) binding protein (PABPC1) and host restriction factor tripartite motif protein 21 (TRIM21). Additionally, we discovered an antagonistic relationship between PRV UL41 and TRIM21. TRIM21, acting as an E3 ubiquitin ligase, binds to UL41 through its SPRY/PRY domain and mediates the degradation of the protein via the K48-ubiquitin-proteasome pathway. This interaction modulates the JAK/STAT pathway, with TRIM21 counteracting the inhibitory effect of UL41. In addition, the residue F78 within PRV UL41 is crucial for modulating mRNA and protein binding and ribonuclease (RNase) function, facilitating interactions with target proteins such as PABPC1 and TRIM21, and inhibiting the JAK/STAT pathway. These findings enhance our understanding of PRV pathogenesis and provide potential targets for developing novel antiviral strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。